This study examines pharmaceutically acceptable inorganic
salts
of memantine, specifically focusing on hydrogen sulfate, sulfate,
and dihydrogen phosphate salts, with the aim of finding alternatives
to the commonly used chloride salt in the treatment of Alzheimer’s
disease. Through comprehensive solid-state characterization, including
powder X-ray diffraction, thermal analysis, and solubility testing,
we unveil complex polymorphic behaviors, reversible solid-state transitions,
and significant differences in solubility and stability among the
salts. Notably, the hydrogen sulfate salt emerges as a promising candidate
for drug formulations, offering improved solubility, nonhygroscopic
nature, and favorable morphological characteristics compared to the
existing chloride salt. This work establishes a foundation for further
investigation into memantine salts as potential therapeutics with
improved efficacy.